Testosterone replacement therapy leads to improvement in the components of metabolic syndrome, with significant reductions observed in waist circumference and triglycerides, though further research is needed to explore long-term effects and safety.
Key Findings
Results
Testosterone replacement therapy produced a statistically significant reduction in waist circumference in male patients with metabolic syndrome.
Meta-analysis used a random effects model to calculate overall effect size as mean difference
Waist circumference reduction had 95% CI: -0.709 to 0.094, p = 0.011
Analysis performed using PQStat v1.8.6 software
Studies were identified through systematic search of PubMed, Scopus, and Cochrane databases without date limits
Results
Testosterone replacement therapy produced a statistically significant reduction in triglyceride levels in male patients with metabolic syndrome.
Triglyceride reduction had 95% CI: -0.474 to 0.120, p = 0.039
Result calculated using random effects model for overall effect size as mean difference
Analysis performed using PQStat v1.8.6 software
Included studies focused on TRT effects in male patients with MS, excluding individuals where type 2 diabetes was the only diagnosis
Methods
The systematic review specifically excluded patients where type 2 diabetes constituted the only diagnosis, focusing on metabolic syndrome more broadly.
Metabolic syndrome comprises several symptoms or disorders that significantly increase the risk of developing atherosclerosis and type 2 diabetes
The study aimed to determine the direct impact of testosterone therapy on the components of MS while excluding type 2 diabetes-only cases
Keywords used in the literature search included 'testosterone therapy', 'metabolic syndrome', and 'men'
Databases searched included PubMed, Scopus, and Cochrane without date limits
Conclusions
The authors conclude that further research is needed to explore the long-term effects and safety of testosterone replacement therapy in patients with metabolic syndrome.
Findings were described as supporting 'the potential therapeutic benefits of testosterone treatment in managing MS'
The authors noted the necessity of further research 'to explore the long-term effects and the safety of this therapy in patients with metabolic syndrome'
The meta-analysis indicates overall improvement across multiple components of metabolic syndrome
Statistically significant effects were specifically demonstrated for waist circumference and triglycerides
Mlynarz N, Miedziaszczyk M, Wieckowska B, Szalek E, Lacka K. (2024). Effects of Testosterone Replacement Therapy on Metabolic Syndrome in Male Patients-Systematic Review.. International journal of molecular sciences. https://doi.org/10.3390/ijms252212221